Core Viewpoint - Company has received a medical device registration certificate for its Digoxin assay kit, which is expected to enhance its product line in the in vitro diagnostic sector and improve its market competitiveness [1] Group 1 - The product name is Digoxin Assay Kit (Magnetic Particle Chemiluminescent Immunoassay) [1] - The kit is designed for the quantitative measurement of Digoxin levels in human serum or plasma [1] - The registration certificate number is 京械注准20252400878 [1] Group 2 - The acquisition of the medical device registration certificate enriches the company's product offerings in the field of in vitro diagnostics [1] - This development is anticipated to positively impact the company's core competitiveness and market expansion capabilities [1] - The company expects this to have a favorable effect on its future operations [1]
九强生物(300406.SZ): 取得医疗器械注册证书